Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
9.54
-1.46 (-13.32%)
At close: Oct 17, 2025, 4:00 PM EDT
9.55
+0.02 (0.16%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Predictive Oncology Revenue
Predictive Oncology had revenue of $2.68K in the quarter ending June 30, 2025, a decrease of -96.01%. This brings the company's revenue in the last twelve months to $1.66M, up 71.65% year-over-year. In the year 2024, Predictive Oncology had annual revenue of $1.62M, down -0.24%.
Revenue (ttm)
$1.66M
Revenue Growth
+71.65%
P/S Ratio
2.80
Revenue / Employee
$69,362
Employees
24
Market Cap
7.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.62M | -3.88K | -0.24% |
| Dec 31, 2023 | 1.63M | 122.24K | 8.12% |
| Dec 31, 2022 | 1.51M | 84.78K | 5.97% |
| Dec 31, 2021 | 1.42M | 168.41K | 13.45% |
| Dec 31, 2020 | 1.25M | -159.29K | -11.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
POAI News
- 4 days ago - Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy - GlobeNewsWire
- 10 days ago - Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy - GlobeNewsWire
- 19 days ago - Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens - GlobeNewsWire
- 23 days ago - Predictive Oncology Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 6 weeks ago - Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients - GlobeNewsWire
- 2 months ago - PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - GlobeNewsWire
- 2 months ago - Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing - GlobeNewsWire